{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:58:02Z","timestamp":1781647082659,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Royal Netherlands Academy of Arts & Sciences","award":["KNAW Ter Meulen Grant"],"award-info":[{"award-number":["KNAW Ter Meulen Grant"]}]},{"name":"Foundation \u201cDe Drie Lichten\u201d"},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["Educational Grant"],"award-info":[{"award-number":["Educational Grant"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["Educational Grant"],"award-info":[{"award-number":["Educational Grant"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Leiden University Medical Center research council Cardio-Vascular cluster","award":["Themes for Innovation funding"],"award-info":[{"award-number":["Themes for Innovation funding"]}]},{"name":"Leiden University Medical Center research council Cardio-Vascular cluster","award":["Themes for Innovation funding"],"award-info":[{"award-number":["Themes for Innovation funding"]}]},{"name":"Leiden University Medical Center research council Cardio-Vascular cluster","award":["Themes for Innovation funding"],"award-info":[{"award-number":["Themes for Innovation funding"]}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005040","name":"Bontius Stichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023406","name":"Rembrandt Institute of Cardiovascular Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023406","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiac resynchronization therapy (CRT) is well-established in acquired heart failure, but evidence in adults with congenital heart disease (ACHD) remains limited. Current guidelines, extrapolated from non-congenital populations, may not fully address the anatomical and electrophysiological complexities in ACHD. This study aimed to evaluate the safety and efficacy of CRT in ACHD, focusing on changes in QRS duration, systemic ventricular function (SVF), and New York Heart Association (NYHA) class.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective multicenter cohort study was conducted across two tertiary ACHD centers. ACHD patients who underwent CRT implantation between 2014 and 2024 were included. Primary outcomes were QRS duration, SVF, and NYHA class at 3, 6, and 12 months post-implantation, and peri-procedural clinical and device-related outcomes were assessed. Mixed models were used to analyze longitudinal changes, adjusting for de novo vs. upgrade CRT implantation, left bundle branch block (LBBB) vs. non-LBBB QRS morphology, and systemic left vs. right ventricle (sRV) anatomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      101 patients were included. The mean age was 53\u2009\u00b1\u200914 year, 41 (40.6%) were female and 48 (47.5%) underwent an upgrade procedure to CRT. Twenty-two patients (21.8%) had mild, 57 (56.4%) moderate, and 22 (21.8%) severe congenital heart disease, and 16 (15.8%) had a sRV. Six patients (5.9%) experienced a procedure-related complication requiring revision (6.6 per 100 patient-years follow-up), and one patient (1.0%) died from end-stage heart failure in the year after CRT implantation. CRT was associated with significant improvements in QRS duration, SVF, and NYHA class at 3, 6, and 12 months (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05 for all). QRS reduction was more pronounced after upgrade procedures. Improvements in QRS, SVF, and NYHA class extended to patients with a sRV and with non-LBBB QRS morphology. At one year follow-up, 68 patients (72.3%) showed improvement of at least 1 class of NYHA and\/or SVF.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study supports CRT as a safe and effective therapy in ACHD patients, including those with sRV or non-LBBB QRS morphology, emphasizing the need for individualized decision-making beyond standard guidelines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-026-05818-5","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T07:07:39Z","timestamp":1775545659000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of cardiac resynchronization therapy in adults with congenital heart disease"],"prefix":"10.1186","volume":"26","author":[{"given":"Ralph M.L.","family":"Neijenhuis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert A.C.","family":"Zwaenepoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivienne","family":"Ezzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieselot","family":"van Erven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Schalij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinit","family":"Sawhney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia L.M.A.","family":"Beeres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly L.","family":"Daw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Wouter","family":"Jukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique R.M.","family":"Jongbloed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Zemrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia D.","family":"Egorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"issue":"6","key":"5818_CR1","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/eurheartj\/ehaa554","volume":"42","author":"H Baumgartner","year":"2020","unstructured":"Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller G-P, et al. 2020 ESC Guidelines for the management of adult congenital heart disease: The Task Force for the management of adult congenital heart disease of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Adult Congenital Heart Disease (ISACHD). Eur Heart J. 2020;42(6):563\u2013645.","journal-title":"Eur Heart J"},{"issue":"15","key":"5818_CR2","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJMoa050496","volume":"352","author":"JG Cleland","year":"2005","unstructured":"Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352(15):1539\u201349.","journal-title":"N Engl J Med"},{"issue":"24","key":"5818_CR3","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1056\/NEJMoa013168","volume":"346","author":"WT Abraham","year":"2002","unstructured":"Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346(24):1845\u201353.","journal-title":"N Engl J Med"},{"issue":"21","key":"5818_CR4","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1056\/NEJMoa032423","volume":"350","author":"MR Bristow","year":"2004","unstructured":"Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350(21):2140\u201350.","journal-title":"N Engl J Med"},{"issue":"35","key":"5818_CR5","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1093\/eurheartj\/ehab364","volume":"42","author":"M Glikson","year":"2021","unstructured":"Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021;42(35):3427\u2013520.","journal-title":"Eur Heart J"},{"key":"5818_CR6","unstructured":"Gurvitz M, Krieger EV, Fuller S, Davis LL, Kittleson MM, Aboulhosn JA et al. 2025 ACC\/AHA\/HRS\/ISACHD\/SCAI Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2025."},{"key":"5818_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ijcard.2018.10.014","volume":"273","author":"AK Fl\u00fcgge","year":"2018","unstructured":"Fl\u00fcgge AK, Wasmer K, Orwat S, Abdul-Khaliq H, Helm PC, Bauer U, et al. Cardiac resynchronization therapy in congenital heart disease: Results from the German National Register for Congenital Heart Defects. Int J Cardiol. 2018;273:108\u201311.","journal-title":"Int J Cardiol"},{"issue":"21","key":"5818_CR8","doi-asserted-by":"publisher","first-page":"e012744","DOI":"10.1161\/JAHA.119.012744","volume":"8","author":"Y Yin","year":"2019","unstructured":"Yin Y, Dimopoulos K, Shimada E, Lascelles K, Griffiths S, Wong T, et al. Early and Late Effects of Cardiac Resynchronization Therapy in Adult Congenital Heart Disease. J Am Heart Assoc. 2019;8(21):e012744.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"5818_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/pace.13670","volume":"42","author":"F Leyva","year":"2019","unstructured":"Leyva F, Zegard A, Qiu T, de Bono J, Thorne S, Clift P, et al. Long-term outcomes of cardiac resynchronization therapy in adult congenital heart disease. Pacing Clin Electrophysiol. 2019;42(6):573\u201380.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"7","key":"5818_CR10","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/pace.14721","volume":"46","author":"SE Thompson","year":"2023","unstructured":"Thompson SE, Hudsmith LE, Bowater SE, Clift P, Marshall H, Leyva F, et al. Cardiac resynchronization therapy in adults with structural congenital heart disease and chronic heart failure. Pacing Clin Electrophysiol. 2023;46(7):665\u201373.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"2","key":"5818_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/europace\/euw386","volume":"20","author":"Z Koyak","year":"2018","unstructured":"Koyak Z, de Groot JR, Krimly A, Mackay TM, Bouma BJ, Silversides CK, et al. Cardiac resynchronization therapy in adults with congenital heart disease. Europace. 2018;20(2):315\u201322.","journal-title":"Europace"},{"issue":"19","key":"5818_CR12","first-page":"1463","volume":"38","author":"C Daubert","year":"2017","unstructured":"Daubert C, Behar N, Martins RP, Mabo P, Leclercq C. Avoiding non-responders to cardiac resynchronization therapy: a practical guide. Eur Heart J. 2017;38(19):1463\u201372.","journal-title":"Eur Heart J"},{"issue":"36","key":"5818_CR13","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021;42(36):3599\u2013726.","journal-title":"Eur Heart J"},{"issue":"6","key":"5818_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/eurheartj\/ehaa554","volume":"42","author":"H Baumgartner","year":"2021","unstructured":"Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021;42(6):563\u2013645.","journal-title":"Eur Heart J"},{"issue":"36","key":"5818_CR15","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599\u2013726.","journal-title":"Eur Heart J"},{"issue":"12","key":"5818_CR16","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1016\/j.jacc.2005.05.096","volume":"46","author":"AM Dubin","year":"2005","unstructured":"Dubin AM, Janousek J, Rhee E, Strieper MJ, Cecchin F, Law IH, et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol. 2005;46(12):2277\u201383.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"5818_CR17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/jama.2013.8641","volume":"310","author":"PN Peterson","year":"2013","unstructured":"Peterson PN, Greiner MA, Qualls LG, Al-Khatib SM, Curtis JP, Fonarow GC, et al. QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy. JAMA. 2013;310(6):617\u201326.","journal-title":"JAMA"},{"issue":"5","key":"5818_CR18","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1161\/01.CIR.57.5.867","volume":"57","author":"E Krongrad","year":"1978","unstructured":"Krongrad E. Prognosis for patients with congenital heart disease and postoperative intraventricular conduction defects. Circulation. 1978;57(5):867\u201370.","journal-title":"Circulation"},{"issue":"1","key":"5818_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1540-8167.2008.01274.x","volume":"20","author":"F Cecchin","year":"2009","unstructured":"Cecchin F, Frangini PA, Brown DW, Fynn-Thompson F, Alexander ME, Triedman JK, et al. Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution. J Cardiovasc Electrophysiol. 2009;20(1):58\u201365.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"14","key":"5818_CR20","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/hrt.2008.160465","volume":"95","author":"J Janousek","year":"2009","unstructured":"Janousek J, Gebauer RA, Abdul-Khaliq H, Turner M, Kornyei L, Grollmuss O, et al. Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates. Heart. 2009;95(14):1165\u201371.","journal-title":"Heart"},{"issue":"6","key":"5818_CR21","doi-asserted-by":"publisher","first-page":"e018302","DOI":"10.1161\/JAHA.120.018302","volume":"10","author":"P Kubu\u0161","year":"2021","unstructured":"Kubu\u0161 P, Rub\u00e1\u010dkov\u00e1 Popelov\u00e1 J, Kovanda J, Sedl\u00e1\u010dek K, Janou\u0161ek J. Long-Term Outcome of Patients With Congenital Heart Disease Undergoing Cardiac Resynchronization Therapy. J Am Heart Assoc. 2021;10(6):e018302.","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"5818_CR22","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1016\/j.hrthm.2018.08.017","volume":"15","author":"JP Moore","year":"2018","unstructured":"Moore JP, Cho D, Lin JP, Lluri G, Reardon LC, Aboulhosn JA, et al. Implantation techniques and outcomes after cardiac resynchronization therapy for congenitally corrected transposition of the great arteries. Heart Rhythm. 2018;15(12):1808\u201315.","journal-title":"Heart Rhythm"},{"issue":"22","key":"5818_CR23","doi-asserted-by":"publisher","first-page":"e025121","DOI":"10.1161\/JAHA.121.025121","volume":"11","author":"RK Kharbanda","year":"2022","unstructured":"Kharbanda RK, Moore JP, Lloyd MS, Galotti R, Bogers A, Taverne Y, et al. Cardiac Resynchronization Therapy for Adult Patients With a Failing Systemic Right Ventricle: A Multicenter Study. J Am Heart Assoc. 2022;11(22):e025121.","journal-title":"J Am Heart Assoc"},{"key":"5818_CR24","unstructured":"Fusco F, Scognamiglio G, Dellborg M, Dehghani P, Jameson SM, Kay WA et al. Cardiac resynchronisation therapy among adults with a systemic right ventricle: a multicentre experience. Heart. 2025:heartjnl\u20132025."},{"issue":"4","key":"5818_CR25","doi-asserted-by":"publisher","first-page":"101667","DOI":"10.1016\/j.jacadv.2025.101667","volume":"4","author":"BL Pinsker","year":"2025","unstructured":"Pinsker BL, Moore JP, Bashore TM, Krasuski RA. Permanent Cardiac Pacing in the Fontan Population: A Contemporary Review of Indications, Approaches, and Outcomes. JACC Adv. 2025;4(4):101667.","journal-title":"JACC Adv"},{"issue":"10","key":"5818_CR26","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1111\/jce.15213","volume":"32","author":"\u00d3 Cano","year":"2021","unstructured":"Cano \u00d3, Dandamudi G, Schaller RD, P\u00e9rez-Rosell\u00f3 V, Ayala HD, Izquierdo M, et al. Safety and feasibility of conduction system pacing in patients with congenital heart disease. J Cardiovasc Electrophysiol. 2021;32(10):2692\u2013703.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"4","key":"5818_CR27","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.jacep.2020.09.015","volume":"7","author":"G Dandamudi","year":"2021","unstructured":"Dandamudi G, Simon J, Cano O, Master V, Koruth JS, Naperkowski A, et al. Permanent His Bundle Pacing in Patients With Congenital Complete Heart Block: A Multicenter Experience. JACC Clin Electrophysiol. 2021;7(4):522\u20139.","journal-title":"JACC Clin Electrophysiol"},{"key":"5818_CR28","doi-asserted-by":"crossref","unstructured":"Moore JP, Gallotti R, Shannon KM, Pilcher T, Vinocur JM, Cano \u00d3 et al. Permanent conduction system pacing for congenitally corrected transposition of the great arteries: A Pediatric and Congenital Electrophysiology Society (PACES)\/International Society for Adult Congenital Heart Disease (ISACHD) Collaborative Study. Heart Rhythm. 2020.","DOI":"10.1016\/j.hrthm.2020.01.033"},{"key":"5818_CR29","doi-asserted-by":"crossref","unstructured":"Zwaenepoel BAC, Neijenhuis RML, Veldtman G, Blom NA, Jukema JW, Jongbloed MRM et al. Effectiveness of Cardiac Resynchronization Therapy in Adult Congenital Heart Disease: A Meta-Analysis of Biventricular and Conduction System Pacing Outcomes. Heart Rhythm. 2026.","DOI":"10.1016\/j.hrthm.2026.01.004"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05818-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05818-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05818-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:34:27Z","timestamp":1781645667000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05818-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5818"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05818-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of the LUMC (Medical Research Involving Human Subjects Act [WMO] committee division 1, protocol reference 2023-035). At Barts Heart Centre, the study was approved in accordance with local institutional policy. All tests and procedures were performed as part of standard clinical care, and the need for written informed consent was waived. The study was conducted in accordance with the ethical standards of the relevant institutional and national research committees and complied with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A.D.E. received speaker and consultancy fees from Medtronic (MN, United States), Boston Scientific (MA, United States), and Abbott (IL, United States). S.L.M.A.B. received speaker and consultancy fees from Medtronic (MN, United States) and Boston Scientific (MA, United States).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"423"}}